Abstract
Aims and Objectives: The aim of this study includes impact of PCOS on infertility.
Materials and Methods: The study includes evaluation and investigation of 100 cases of infertile females over a period of 3 years from 2007 to 2009 in Gandhi Hospital, Secunderabad, Telangana. A detailed history for every complaint in all the cases was taken by the in charge gynecologist.
Results: PCOS accounted for about 30% of the total infertility cases.
Conclusion: This study attempts to focus the impact of PCOS on reproductive performance.
Keywords: PCOS, Infertility, Anovulaton.
References
- Richard Scott Lucidi, MD, FACOGAssociate Professor of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine is a member of the American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine.
- March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod2010; 25:544–51.
- Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89:2745–2749.
- Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J ClinEndocrinol Metab 2000; 85:2434–3515.
- Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84:4006–4011.
- Boyle JA, Cunningham J, O’Dea K, Dunbar T, Norman RJ.Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust 2012; 196:62–66.
- Teede H, Deeks A, Moran L. Polycystic ovary syndrome: Acomplex condition with psychological, reproductive and metabolic manifestations that impact on health across the lifespan. BMC Medicine 2010; 8:41.
- Diamanti-Kandarakis E, Papavassiliou AG. Molecularmechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006; 12:324–332.
- Rotterdam ESHRE/ASRM-Sponsored PCOS ConsensusWorkshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19–25.
- Azziz R, Carmina E, Dewailly D, et al. Positions statement:Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237–4245.
- Mary E. Fallat M.D.Yong Siow Ph.D. Maureen Marra M.D. Christine CookM.D. Alberto Carrillo Ph.D.: Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertility and Sterility May 1997; 67 :962-965
Corresponding Author
Anagani Jayashree
Associate Professor, Department of Anatomy,
Malla Reddy Medical College for Women, Suraram, Hyderabad, T.S
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v5i11.61
